Page last updated: 2024-12-05

dyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dyrene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

anilazine : A member of the class of triazenes that is dichlorotriazene in which the hydrogen is replaced by an o-chloroanilino group. A fungicide formerly used to control leaf spots and downy mildew, it is no longer approved for use within the European Union. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7541
CHEMBL ID464135
CHEBI ID82076
SCHEMBL ID13280
MeSH IDM0046064

Synonyms (83)

Synonym
AC-12678
anilazine
triasym
direz
nsc-3851
anilazin
triazine (pesticide)
nsc3851
nci-c08684
4,3,5-triazin-2-amine
dyrene 50w
wln: t6n cn enj bmr bg & dg fg
bortrysan
2,4-dichloro-6-(o-chloranilino)-s-triazine
triasyn
ent 26,058
b-622
triazin
dyrene
zinochlor
1,5-triazin-2-amine, 4,6-dichloro-n-(2-chlorophenyl)-
101-05-3
s-triazine,4-dichloro-6-(o-chloroanilino)-
2,4-dichloro-6-(o-chloroanilino)-s-triazine
kemate
1,3,5-triazin-2-amine, 4,6-dichloro-n-(2-chlorophenyl)-
4, 6-dichloro-n-(2-chlorophenyl)-1,3,5-triazin-2-amine
1,3,5-triazin-2-amine, 4, 6-dichloro-n-(2-chlorophenyl)-
2, 4-dichloro-6-(o-chloroanilino)-s-triazine
s-triazine, 2,4-dichloro-6-(o-chloroanilino)-
2, 4-dichloro-6-(2-chloroanilino)-1,3,5-triazine
4,6-dichloro-n-(2-chlorophenyl)-1,3,5-triazin-2-amine
2, 4-dichloro-6-(o-chloranilino)-s-triazine
ent 26, 058
n-(2-chlorophenyl)-n-(4,6-dichloro-1,3,5-triazin-2-yl)amine
NCGC00090810-01
anilazine [bsi:iso]
nsc 3851
ccris 43
(o-chloroanilino)dichlorotriazine
2,4-dichloro-6-(2-chloroanilino)-1,3,5-triazine
brn 0223133
hsdb 1567
triazine (van)
2-chloro-n-(4,6-dichloro-1,3,5-triazin-2-yl)aniline
2,4-dichloro-6-o-chloranilino-s-triazine
epa pesticide chemical code 080811
ai3-26058
dyrene flussig
caswell no. 302
einecs 202-910-5
aniyaline
2-(2-chloranilin)-4,6-dichlor-1,3,5-triazin [german]
NCGC00090810-02
chebi:82076 ,
CHEMBL464135
NCGC00090810-03
AKOS009156485
2-(2-chloranilin)-4,6-dichlor-1,3,5-triazin
unii-c6e8y03zjn
5-26-08-00019 (beilstein handbook reference)
c6e8y03zjn ,
C18935
tox21_301181
cas-101-05-3
NCGC00255079-01
dtxsid9020089 ,
dtxcid6089
6-(2-chloroanilino)-2,4-dichloro-1,3,5-triazine
FT-0602841
SCHEMBL13280
anilazine [iso]
anilazine [hsdb]
anilazine [mi]
dairene
2-(2-chlorophenylamino)-4,6-dichloro-s-triazine
dairin
direz; dyrene
J-000315
anilazine, pestanal(r), analytical standard
Q413886
1219802-20-6
(r)-3-amino-3-(4-cyano-phenyl)-propionicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
triazinesCompounds based on a triazine skeleton.
organochlorine pesticideAny organochlorine compound that has been used as a pesticide.
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.35840.007215.758889.3584AID1224835
interleukin 8Homo sapiens (human)Potency47.30790.047349.480674.9780AID651758
pregnane X receptorRattus norvegicus (Norway rat)Potency28.18380.025127.9203501.1870AID651751
thyroid stimulating hormone receptorHomo sapiens (human)Potency6.30960.001318.074339.8107AID926; AID938
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency8.46370.001022.650876.6163AID1224838; AID1224893
retinoid X nuclear receptor alphaHomo sapiens (human)Potency35.48130.000817.505159.3239AID588546
pregnane X nuclear receptorHomo sapiens (human)Potency29.89870.005428.02631,258.9301AID1346982; AID720659
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.07760.001024.504861.6448AID743215
aryl hydrocarbon receptorHomo sapiens (human)Potency68.51990.000723.06741,258.9301AID743085
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency50.11870.010039.53711,122.0200AID588545
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency25.11894.466824.832944.6684AID651749
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency25.99410.000627.21521,122.0200AID651741; AID720636; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's4 (30.77)18.2507
2000's2 (15.38)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.17 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index116.72 (26.88)
Search Engine Supply Index3.90 (0.95)

This Compound (43.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]